mRNA-1012.1

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1012.1, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults [Phase 1, Phase 2]

See pricing